Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population

International Journal of Immunogenetics

Volumn 37, Issue 4, 2010, Pages 289-291

  Yun, J Y ^a   Uhm, Y K ^a   Kim, H J ^a,b   Lim, S H ^a   Chung, J H ^a   Shin, M K ^a   Yim, S V ^a   Lee, M H ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NONSEGMENTAL VITILIGO; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

ADULT; AUTOIMMUNE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPUBLIC OF KOREA; VITILIGO; YOUNG ADULT;

EID: 78651100346     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00923.x     Document Type: Article

References (10)

1. Basak, P.Y., Adiloglu, A.K., Ceyhan, A.M., Tas, T. & Akkaya, V.B. (2009) The role of helper and regulatory T cells in the pathogenesis of vitiligo. J Am Acad Dermatol, 60, 256.
2. Goggins, M., Shekher, M., Turnacioglu, K., Yeo, C.J., Hruban, R.H. & Kern, S.E. (1998) Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Research, 58, 5329.
3. Jin, G., Wang, L., Chen, W., Hu, Z., Zhou, Y., Tan, Y. et al. (2007) Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. International Journal of Cancer, 120, 1330.
4. Jin, G., Deng, Y., Miao, R., Hu, Z., Zhou, Y., Tan, Y. et al. (2008) TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: A case-control analysis in a Chinese population. Journal of Cancer Research and Clinical Oncology, 134, 345.
5. Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fabiani, M. et al. (2002) New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Research, 15, 87.
6. Numata, S., Ueno, S., Iga, J., Yamauchi, K., Hongwei, S., Hashimoto, R. et al. (2008) TGFBR2 gene expression and genetic association with schizophrenia. Journal of Psychiatric Research, 42, 425.
7. Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G.J., Loda, M. & Fuchs, C.S. (2007) TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Human Pathology, 38, 614.
8. Pyzik, M. & Piccirillo, C.A. (2006) The TGF-beta1 / Foxp3 regulatory axis in immune self-tolerance: Implications for health and disease. Inflammation & Allergy Drug Targets, 5, 167.
9. Rezaei, N., Gavalas, N.G., Weetman, A.P. & Kemp, E.H. (2007) Autoimmunity as an aetiological factor in vitiligo. JEADV, 21, 865.
10. Spritz, R.A. (2008) The genetics of generalized vitiligo. Current Directions in Autoimmunity, 10, 244.